Effect of metallothioneins on transformation of gelatinase A from human fibroblast WI-38 cells

Cancer Letters

Volumn 105, Issue 2, 1996, Pages 175-180

  Haga, Arayo ^a   Nagase, Hisamitsu ^a   Kito, Hideaki ^a   Sato, Takahiko ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Gelatinase A; Metallothionein; Tumor metastasis; WI 38 cells

Indexed keywords

GELATINASE; HEAVY METAL; METALLOTHIONEIN;

ANIMAL TISSUE; ARTICLE; COLLAGEN DEGRADATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME DEGRADATION; ENZYME REGULATION; ENZYME SUBSTRATE COMPLEX; FIBROBLAST; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RAT;

EID: 0030564997     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3835(96)04277-2     Document Type: Article

References (33)

1. [1] Docherty, A.J.P. and Murphy, G. (1990) Sequencing and cloning an expression of mammalian stromelysin. Ann. Rheum. Dis., 49, 469-479.
2. [2] Okada, Y., Morodomi, T., Enghild, J.J., Suzuki, K., Yasui, A., Nakanishi, I., Salvesen, G. and Nagase, H. (1990) Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts: purification and activation of the precursor and enzymic properties. Eur. J. Biochem., 194, 721-730.
3. [3] Murphy, G., Cockett, M.I., Ward, R.V. and Docherty, A.J.P. (1991) Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan. Biochem. J., 277, 277-279.
4. [4] Docherty, A.J.P., O'Connel, J., Crabbe, T., Angal, S. and Murphy, G. (1992) The matrix metalloproteinases and their natural inhibitors: prospects for treating degenerative tissue diseases. Trends Biotechnol., 10, 200-207.
5. [5] Terranova, V.P., Hujanen, E.S. and Martin, G.R. (1986) Basement membrane and the invasive activity of metastatic tumor cells. J. Natl. Cancer Inst., 77, 311-316.
6. [6] Stetler-Stevenson, W.G. (1990) Type IV collagenases in tumor invasion and metastasis. Cancer Metastasis Rev., 9, 289-303.
7. [7] Azzam, H.S., Arand, G., Lippman, M.E. and Thompson, E.W. (1993) Association of MMP-2 activation potential with metastatic progression in human breast cancer cell lines independent of MMP-2 production. J. Natl. Cancer Inst., 85, 1758-1764.
8. r 72,000) expression in human prostate: benign and malignant tissue. Cancer Res., 53, 878-883.
9. [9] Overall, C.M. and Sodek, J. (1990) Concanavalin A produces a matrix-degradative phenotype in human fibroblasts. J. Biol. Chem., 265, 21141-21151.
10. r 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines. Cancer Res., 50, 6184-6191.
11. [11] Kataoka, H., DeCastro, R., Zucker, S. and Biswas, C. (1993) Tumor cell-derived collagenase-stimulatory factor increases expression of interstitial collagenase, stromelysin, and 72-kDa gelatinase. Cancer Res., 53, 3154-3158.
12. [12] Ward, R.V., Atkinson, S.J., Slocombe, P.M., Docherty, A.J.P., Reynolds, J.J. and Murphy, G. (1991) Tissue inhibitor of metalloproteinases-2 inhibits the activation of 72 kDa progelatinase by fibroblast membranes. Biochim. Biophys. Acta, 1079, 242-246.
13. [13] Ward, R.V., Hembry, R.M., Reynolds, J.J. and Murphy, G. (1991) The purification of tissue inhibitor of metalloproteinase-2 from its 72 kDa progelatinase complex. Biochem. J., 278, 179-187.
14. [14] Strongin, A.Y., Marmer, B.L., Grant, G.A. and Goldberg, G.I. (1993) Plasma membrane-dependent activation of the 72-kDa type IV collagenase is prevented by complex formation with TIMP-2. J. Biol. Chem., 268, 14033-14039.
15. 73 active-site zinc complex in latency and a 'cysteine switch' mechanism for activation. Proc. Natl. Acad. Sci. USA, 87, 364-368.
16. [16] Gavrilovic, J. and Murphy, G. (1989) The role of plasminogen in cell-mediated collagen degradation. Cell Biol. Int. Rep., 13, 367-375.
17. [17] Murphy, G., Ward, R.V., Gavrilovic, J. and Atkinson, S. (1992) Physiological mechanisms for metalloproteinase activation. Matrix, 1, 224-230.
18. [18] Sato, H., Takino, T., Okada, Y., Cao, J., Shinagawa, A., Yamamoto, E. and Seiki, M. (1994) A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature, 370, 61-65.
19. [19] Margoshes, M. and Vallee, B.L. (1957) A cadmium protein from equine kidney cortex. J. Am. Chem. Soc., 79, 4813-4814.
20. [20] Waalkes, M.P. and Goering, P.L. (1990) Metallothionein and other cadmium-binding proteins: recent developments. Chem. Res. Toxicol., 3, 281-288.
21. [21] Hamer, D.H. (1986) Metallothionein. Annu. Rev. Biochem., 55, 913-951.
22. [22] Li, T.-Y., Kraker, A.J., Shaw, III, C.F. and Petering, D.A. (1980) Ligand substitution reactions of metallothioneins with EDTA and apocarbonic anhydrase. Proc. Natl. Acad. Sci. USA, 77, 6334-6338.
23. [23] Goering, P.L. and Fowler, B.A. (1987) Kidney zinc-thionein regulation of aminolevulinic acid dehydratase inhibition by lead. Arch. Biochem. Biophys., 253, 48-55.
24. [24] Onosaka, S. and Cherian, M.G. (1981) The induced synthesis of metallothionein in various tissue of rat in response to metals, I: effect of repeated injection of cadmium salts. Toxicology, 22, 91-101.
25. [25] Heussen, C. and Dowdle, E.B. (1980) Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal. Biochem., 102, 196-202.
26. [26] Nagai, Y., Hori, H., Hattori, S., Sasaki, K. and Sato, T. (1984) A micro-assay method of collagenase activity and its application in the study of collagen metabolism in pathological tissues. Enshyou, 4, 123-130.
27. A gene. Nature, 308, 513-519.
28. [28] Karin, M. and Holtgreve, H. (1984) Nucleotide sequence requirements for transient expression of human metallothionein-IIA-thymidine kinase fusion genes. DNA, 3, 319-326.
29. [29] Nakajima, M. and Chop, A.M. (1991) Tumor invasion and extracellular matrix degradative enzymes: regulation of activity by organ factors. Cancer Biol., 2, 115-127.
30. [30] Suzuki, K. (1993) Metallothionein in biological regulation of metals. Jpn. J. Nutr. Assess., 10, 33-40.
31. [31] Murphy, G., Willenbrock, F., Ward, R.D., Cockett, M.I., Eaton, D. and Docherty, A.J.P. (1992) The C-terminal domain of 72 kDa gelatinase A is not required for catalysis, but is essential for membrane activation and modulates interactions with tissue inhibitors of metalloproteinases. Biochem. J., 283, 637-641.
32. [32] Chen, W.-T., Lee, C-C, Goldstein, L., Bernier, S., Liu, C.H.L., Lin, C-Y., Yeh, Y., Monsky, W.L., Kelly, T., Dai, M., Zhou, J.-Y. and Mueller, S.C. (1994) Membrane proteases as potential diagnostic and therapeutic targets for breast malignancy. Breast Cancer Res. Treat., 31, 217-226.
33. [33] De, S.K., McMaster, M.T. and Andrews, G.K. (1990) Endotoxin induction of metallothionein gene expression. J. Biol. Chem., 265, 15267-15274.